 Anti-Anxiety Agents
"Anti-Anxiety Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here.
| Descriptor ID |
D014151
|
| MeSH Number(s) |
D27.505.696.277.950.015 D27.505.954.427.210.950.015 D27.505.954.427.700.872.015
|
| Concept/Terms |
Anti-Anxiety Agents- Anti-Anxiety Agents
- Agents, Anti-Anxiety
- Anti Anxiety Agents
- Anxiolytic Agents
- Agents, Anxiolytic
- Tranquilizing Agents, Minor
- Agents, Minor Tranquilizing
- Minor Tranquilizing Agents
- Tranquillizing Agents, Minor
- Agents, Minor Tranquillizing
- Minor Tranquillizing Agents
- Anti-Anxiety Drugs
- Anti Anxiety Drugs
- Drugs, Anti-Anxiety
- Anxiolytics
Anti-Anxiety Effect- Anti-Anxiety Effect
- Anti Anxiety Effect
- Effect, Anti-Anxiety
- Anxiolytic Effects
- Effects, Anxiolytic
- Antianxiety Effects
- Effects, Antianxiety
- Anxiolytic Effect
- Effect, Anxiolytic
- Anti-Anxiety Effects
- Anti Anxiety Effects
- Effects, Anti-Anxiety
- Antianxiety Effect
- Effect, Antianxiety
|
Below are MeSH descriptors whose meaning is more general than "Anti-Anxiety Agents".
Below are MeSH descriptors whose meaning is more specific than "Anti-Anxiety Agents".
This graph shows the total number of publications written about "Anti-Anxiety Agents" by people in this website by year, and whether "Anti-Anxiety Agents" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 0 | 1 | | 1995 | 0 | 1 | 1 | | 1997 | 1 | 0 | 1 | | 1998 | 1 | 0 | 1 | | 1999 | 0 | 1 | 1 | | 2000 | 0 | 2 | 2 | | 2005 | 1 | 0 | 1 | | 2007 | 2 | 0 | 2 | | 2008 | 0 | 1 | 1 | | 2009 | 0 | 1 | 1 | | 2010 | 3 | 2 | 5 | | 2011 | 0 | 1 | 1 | | 2013 | 1 | 1 | 2 | | 2014 | 0 | 1 | 1 | | 2015 | 1 | 0 | 1 | | 2016 | 2 | 0 | 2 | | 2017 | 0 | 1 | 1 | | 2019 | 1 | 0 | 1 | | 2020 | 0 | 1 | 1 | | 2022 | 1 | 0 | 1 | | 2023 | 2 | 0 | 2 | | 2024 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Anti-Anxiety Agents" by people in Profiles.
-
Bidwell LC, Martin-Willett R, Skrzynski C, Lisano J, Ortiz Torres M, Giordano G, Hutchison KE, Bryan AD. Acute and Extended Anxiolytic Effects of Cannabidiol in Cannabis Flower: A Quasi-Experimental ad libitum Use Study. Cannabis Cannabinoid Res. 2024 Aug; 9(4):1015-1027.
-
Janakiram C, Okunev I, Tranby EP, Fontelo P, Iafolla TJ, Dye BA. Opioids for acute and chronic pain when receiving psychiatric medications. PLoS One. 2023; 18(9):e0286179.
-
Mehrhoff EA, Booher WC, Hutchinson J, Schumacher G, Borski C, Lowry CA, Hoeffer CA, Ehringer MA. Diazepam effects on anxiety-related defensive behavior of male and female high and low open-field activity inbred mouse strains. Physiol Behav. 2023 Nov 01; 271:114343.
-
Buchanan CB, Stallworth JL, Joy AE, Dixon RE, Scott AE, Beisang AA, Benke TA, Glaze DG, Haas RH, Heydemann PT, Jones MD, Lane JB, Lieberman DN, Marsh ED, Neul JL, Peters SU, Ryther RC, Skinner SA, Standridge SM, Kaufmann WE, Percy AK. Anxiety-like behavior and anxiolytic treatment in the Rett syndrome natural history study. J Neurodev Disord. 2022 05 14; 14(1):31.
-
Wang GS, Baker K, Ng P, Janis GC, Leonard J, Mistry RD, Heard K. A randomized trial comparing physostigmine vs lorazepam for treatment of antimuscarinic (anticholinergic) toxidrome. Clin Toxicol (Phila). 2021 Aug; 59(8):698-704.
-
Iyer AS, Holm KE, Bhatt SP, Kim V, Kinney GL, Wamboldt FS, Jacobs MR, Regan EA, Armstrong HF, Lowe KE, Martinez CH, Dransfield MT, Foreman MG, Shinozaki G, Hanania NA, Wise RA, Make BJ, Hoth KF. Symptoms of anxiety and depression and use of anxiolytic-hypnotics and antidepressants in current and former smokers with and without COPD - A cross sectional analysis of the COPDGene cohort. J Psychosom Res. 2019 03; 118:18-26.
-
Lyons DN, Zhang L, Pandya JD, Danaher RJ, Ma F, Miller CS, Sullivan PG, Sirbu C, Westlund KN. Combination Drug Therapy of Pioglitazone and D-cycloserine Attenuates Chronic Orofacial Neuropathic Pain and Anxiety by Improving Mitochondrial Function Following Trigeminal Nerve Injury. Clin J Pain. 2018 02; 34(2):168-177.
-
Rylander M, Winston HR, Medlin H, Hull M, Nussbaum A. The association of cannabis use on inpatient psychiatric hospital outcomes. Am J Drug Alcohol Abuse. 2018; 44(1):73-84.
-
Meyers ML, Mirsky DM, Dannull KA, Tong S, Crombleholme TM. Effects of Maternal Valium Administration on Fetal MRI Motion Artifact: A Comparison Study at High Altitude. Fetal Diagn Ther. 2017; 42(2):124-129.
-
Sant'Ana AB, Weffort LF, de Oliveira Sergio T, Gomes RC, Frias AT, Matthiesen M, Vilela-Costa HH, Yamashita PS, Vasconcelos AT, de Bortoli V, Del-Ben CM, Zangrossi H. Panic-modulating effects of alprazolam, moclobemide and sumatriptan in the rat elevated T-maze. Behav Brain Res. 2016 12 15; 315:115-22.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|